Differences in Immune Tolerance Status between Haploidentical and Unrelated Donor Transplant Recipients Following Tcrαβ/CD19 Cell Depletion for SCID on the Prospective ‘Cside’ Trial | Synapse
March 3, 2026
Differences in Immune Tolerance Status between Haploidentical and Unrelated Donor Transplant Recipients Following Tcrαβ/CD19 Cell Depletion for SCID on the Prospective ‘Cside’ Trial
Key Points
Immune tolerance status varies significantly between haploidentical and unrelated donor transplant recipients.
The study highlights key differences in survival outcomes and immune function post-transplant.
Observational analysis across transplant recipients involved TCRαβ/CD19 cell depletion for severe combined immunodeficiency.
Findings may influence future transplant protocols, especially for SCID patients.